Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to develop a scale to measure the severity of depression with psychotic symptoms (psychotic depression). Furthermore, we hope to detect potential biomarkers (substances in the blood) which can aid in the detection of psychotic depression.

Main hypothesis: A clinically valid rating scale measuring the severity of psychotic depression can be developed.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01518049
Study type Observational
Source Aarhus University Hospital
Contact
Status Completed
Phase N/A
Start date February 2012
Completion date September 2014

See also
  Status Clinical Trial Phase
Completed NCT00240721 - A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder Phase 3
Completed NCT02077829 - Implementation of Illness Management and Recovery in Mental Health Services N/A
Completed NCT01324973 - Web-Based Weight Management for Individuals With Mental Illness N/A
Recruiting NCT04118283 - Assessment and Treatment for Chronic Pain in Veterans With Serious Mental Illness N/A
Completed NCT00627510 - Routine Plasma Level Determination to Compare Actual vs Expected Plasma Levels at Psychiatric Inpatient Admission N/A
Recruiting NCT03919760 - Early Psychosis Intervention - Spreading Evidence-based Treatment
Completed NCT00035802 - A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder Phase 3
Completed NCT02474524 - Self-Management and Recovery Technology Psychosocial Intervention Trial N/A
Completed NCT02321943 - Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study N/A
Terminated NCT00867360 - Treatment of Psychotic Major Depression With Mifepristone Phase 3
Completed NCT00960375 - Smoking Cessation for Veterans With Severe and Persistent Mental Illness Phase 2/Phase 3